The development of CAR-T-cell therapy in Russia is being discussed at the Izvestia press center. Broadcast

A press conference is being held at the Izvestia press center on the topic: "Development of cell therapy in Russia".

How does CAR-T therapy work and what are its advantages? What results did the clinical trial of the first Russian drug show? How effective is this method in the treatment of oncohematological diseases? How is the field of cell therapy developing in Russia and what prospects do patients expect?

Participants:

- Elena Parovichnikova, General Director of the National Research Medical Center of Hematology of the Ministry of Health of the Russian Federation, Chief freelance specialist Hematologist of the Ministry of Health of the Russian Federation, Corresponding Member of the Russian Academy of Sciences, Doctor of Medical Sciences, Professor;

- Apollinaria Bogolyubova-Kuznetsova, Head of the Department of Biomedical Technologies, Head of the Laboratory of Translational Immunology, Head of the Center for High-Precision Genetic Technologies for Medicine at the National Research Medical Center of Hematology of the Ministry of Health of the Russian Federation, Candidate of Biological Sciences;

- Olga Alyoshina, Head of the Department of Cellular and Immune Therapy, Hematologist at the National Research Medical Center of Hematology of the Ministry of Health of the Russian Federation, Candidate of Medical Sciences.